Key Trends and Insights into the Recombinant DNA Technology Market: Growth Rate and Opportunities to 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Future CAGR is Anticipated for the Recombinant DNA Technology Market Over the 2025–2034 Period?
In recent times, the market size of recombinant DNA technology has seen robust growth. The market size is expected to expand from $858.94 billion in 2024 to $920.82 billion in 2025 with a compound annual growth rate (CAGR) of 7.2%. This growth during the historical period is due to factors like healthcare needs, growth in the biopharmaceutical industry, increased investments in research and development, and the advent of personalized medicine.
The market size for recombinant DNA technology is set for substantial expansion in the coming years. It is projected to reach $1318.72 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. The predicted growth during the forecast period is largely due to the increase in chronic illnesses, the rise of new biotech startups, heightened biotech funding, wider spread of biotech markets, along with enhanced consumer understanding and approval. Key forecast period trends include the progression in scientific and gene-editing techniques, cell and gene therapies, the advent of RNA therapeutics, therapeutic uses in infrequent diseases, and the incorporation of Artificial Intelligence and data.
What Are the Primary Drivers Supporting the Growth of the recombinant dna technology Market?
The anticipated upswing in the abundance of chronic illnesses is predicted to fuel the expansion of the recombinant DNA technology market. Chronic illnesses are characterized as disorders that persist for a minimum of a year, needing constant medical attention, limiting regular activities, or both. Recombinant DNA technology has revolutionized healthcare by developing biopharmaceutical proteins used in medicine and by substituting faulty genes with healthy ones via gene therapy, aiming for a complete disease cure. For example, the World Health Organization, an intergovernmental organization based in Switzerland, predicted in February 2024 that over 35 million new cancer cases would emerge by 2050, an increase of 77% in comparison to an estimated 20 million instances in 2022. Hence, the surge in chronic illnesses is steering the progress of the recombinant DNA technology market.
Explore Comprehensive Insights Into The Global Recombinant DNA Technology Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8233&type=smp
Who Are the Influential Players Fueling Innovation and Growth in the Recombinant DNA Technology Market?
Major companies operating in the recombinant DNA technology market are:
• Profacgen BioTech Corp._x000D_
• Amgen Inc._x000D_
• Novartis International AG_x000D_
• GenScript Biotech Corporation_x000D_
• Pfizer Inc._x000D_
What Impact Are Industry Trends Having on the Recombinant DNA Technology Market’s Future Prospects?
The recombinant DNA technology market is seeing a significant trend towards technological innovation. The leading businesses in the sector are concentrating on the creation of novel technologies to maintain their market standing. For example, in August 2022, Bluebird bio, Inc., a biotechnology firm headquartered in the US, introduced ZYNTEGLO, a one-off gene therapy approved by the U.S. Food and Drug Administration (FDA). This treatment targets the genetic origin of beta-thalassemia, opening the possibility for patients to stop regular red blood cell transfusions. It employs an ex-vivo lentiviral vector to modify patient cells, making it the first FDA-approved gene therapy for beta-thalassemia in the U.S. This revolutionary development alleviates the ongoing challenges of handling beta-thalassemia.
Secure Your Global Recombinant DNA Technology Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report
How Are the Key Segments of the Recombinant DNA Technology Market Driving Opportunities and Innovations?
The recombinant DNA technology market covered in this report is segmented –
1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell And Gene Therapy, Gene Editing
2) By Component Type: Expression System, Cloning Vector
3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types
4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types
Subsegments:
1) By Recombinant Protein Drugs: Hormones, Growth Factors
2) By Vaccines: Recombinant Viral Vaccines, Recombinant Bacterial Vaccines, Subunit Vaccines
3) By Genetically Modified Crops: Herbicide-Tolerant Crops, Insect-Resistant Crops, Nutritionally Enhanced Crop
4) By Expression Systems: Bacterial Expression Systems, Yeast Expression Systems, Mammalian Expression Systems
5) By Cell And Gene Therapy: Cell-Based Therapies, Gene Replacement Therapies, CAR T-Cell Therapies
6) By Gene Editing: CRISPR Or Cas9 Technologies, TALENs (Transcription Activator-Like Effector Nucleases), ZFNs (Zinc Finger Nucleases)
What Regions Are Leading the Growth Trajectory of the Recombinant DNA Technology Market?
North America was the largest region in the recombinant DNA technology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant DNA technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Do Experts Define the Scope of the Recombinant DNA Technology Market?
Recombinant DNA technology refers to fusing DNA molecules from other organisms and inserting those DNA molecules into a host organism to build a new genetic combinations useful for science, medicine, agriculture, and industry. The recombinant DNA technology is used to address health issues by creating new medications and vaccines.
Browse Through More Similar Reports By The Business Research Company:
Cellular or Mobile Telephone Services Global Market Report 2024
Cellular Telephones Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report
Cell Based Assays Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
